BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim EJ, Lee JG, Kim JY, Song SH, Joo DJ, Huh KH, Kim MS, Kim BS, Kim YS. Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets. Immunology 2017;152:628-37. [PMID: 28758197 DOI: 10.1111/imm.12804] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Kim EJ, Kim JY, Choi HY, Lee H, Lee J, Kim MS, Kim YS, Huh KH, Kim BS. Systemic Immunomodulatory Effects of Combinatorial Treatment of Thalidomide and Dexamethasone on T Cells and Other Immune Cells. Yonsei Med J 2021;62:137-48. [PMID: 33527793 DOI: 10.3349/ymj.2021.62.2.137] [Reference Citation Analysis]
2 Cari L, De Rosa F, Nocentini G, Riccardi C. Context-Dependent Effect of Glucocorticoids on the Proliferation, Differentiation, and Apoptosis of Regulatory T Cells: A Review of the Empirical Evidence and Clinical Applications. Int J Mol Sci 2019;20:E1142. [PMID: 30845709 DOI: 10.3390/ijms20051142] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
3 Bansal R, Reshef R. Revving the CAR - Combination strategies to enhance CAR T cell effectiveness. Blood Rev 2021;45:100695. [PMID: 32402724 DOI: 10.1016/j.blre.2020.100695] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
4 Chen YQ, Wang CJ, Xie K, Lei M, Chai YS, Xu F, Lin SH. Progranulin Improves Acute Lung Injury through Regulating the Differentiation of Regulatory T Cells and Interleukin-10 Immunomodulation to Promote Macrophage Polarization. Mediators Inflamm 2020;2020:9704327. [PMID: 32565732 DOI: 10.1155/2020/9704327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
5 Li Y, Shi K, Qi F, Yu Z, Chen C, Pan J, Wu G, Chen Y, Li J, Chen Y, Zhou T, Li X, Xia J. Thalidomide combined with short-term low-dose glucocorticoid therapy for the treatment of severe COVID-19: A case-series study. Int J Infect Dis 2021;103:507-13. [PMID: 33333254 DOI: 10.1016/j.ijid.2020.12.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
6 Maciel-fiuza MF, Costa PDSS, Kowalski TW, Schuler-faccini L, Bonamigo RR, Vetoratto R, Eidt LM, de Moraes PC, Silveira MIDS, Camargo LMA, Callegari-jacques SM, Castro SMDJ, Vianna FSL. Evaluation of Polymorphisms in Toll-Like Receptor Genes as Biomarkers of the Response to Treatment of Erythema Nodosum Leprosum. Front Med 2022;8:713143. [DOI: 10.3389/fmed.2021.713143] [Reference Citation Analysis]
7 Krstevska Balkanov S, Trajkova S, Genadieva Stavric S, Pivkova Veljanovska A, Popova Labacevska M, Spasovski D, Rambabova Bushljetik I, Kalcev G, Panovska Stavridis I. Myeloma multiplex treatment and overall survival. Maced Pharm Bull 2022;67:79-90. [DOI: 10.33320/10.33320/maced.pharm.bull.2021.67.01.008] [Reference Citation Analysis]
8 Zhang Y, Yang Y, Li X, Chen D, Tang G, Men T. Thalidomide ameliorate graft chronic rejection in an allogenic kidney transplant model. Int Immunopharmacol 2019;71:32-9. [PMID: 30877871 DOI: 10.1016/j.intimp.2018.12.035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]